India's pharmaceutical landscape presents a complex picture, largely shaped by the significant influence of a few prominent players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of industry concentration that warrants scrutiny. These established companies, including names li